A personalized paradigm in the treatment of platinum-resistant ovarian cancer: A cost utility analysis of genomic-based versus cytotoxic therapy

John Joseph Wallbillich, B Forde, LJ Havrilesky, DE Cohn

Research output: Contribution to journalArticlepeer-review

13 Scopus citations
Original languageEnglish (US)
Article number27106017
Pages (from-to)144-149
Number of pages6
JournalGynecologic Oncology
Issue number1
StatePublished - Jul 2016

Cite this